Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its reven...
Illumina Inc (ILMN) has a valuation score of 74/100 (moderate), profitability score of 82/100 (strong), financial health score of 93/100 (strong), Piotroski F-Score of 7/9, Altman Z-Score of 5.56 (safe zone), revenue growth of -1.8% YoY.
Neutral
Analyst Consensus
BuyWall Street consensus estimates — not a PMP forecast · Updated Sep 2, 2026
Analyst Recommendations28 analysts · 2026-09-01
7
9
9
2
Strong Buy 7Buy 9Hold 9Sell 2Strong Sell 1
Recent Market Moves
See all ILMN moves →| Date | Session | Price | Move | Z-Score |
|---|---|---|---|---|
| Aug 28 | After-hours | $214.90 | -5.62% | -2.18 |
| Aug 6 | Regular | $190.01 | -4.93% | -3.29 |
| Aug 6 | After-hours | $192.00 | -3.94% | -2.63 |